Deleted in Liver Cancer 2 (DLC2) protein expression in hepatocellular carcinoma

Submitted: 12 September 2018
Accepted: 8 February 2019
Published: 18 February 2019
Abstract Views: 938
PDF: 522
HTML: 16
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Deleted in Liver Cancer (DLC) proteins belong to the family of RhoGAPs and are believed to operate as negative regulators of the Rho family of small GTPases. So far, the role of the first identified member from the DLC family, DLC1, was established as a tumor suppressor in hepatocellular carcinoma. The function of its close family relative, DLC2 is unequivocal. In the present study we attempted to determine whether the loss of DLC2 is a common feature of hepatocellular carcinoma tissue. We examined two types of hepatocellular carcinoma- typical and fibrolamellar one. Our analysis revealed that DLC2 protein is not diminished in cancer tissue when compared to non-cancerous liver specimens. What is more, we observed DLC2 to be more abundantly expressed in cancer tissue, particularly in tumors with the inflammation background. In addition, we found that DLC2 gene status was diploid in virtually all tumor samples examined. Our results indicate that DLC2 is not diminished in hepatocellular carcinoma cells. It appears that members of the DLC family, although structurally highly related, may function differently in cancer cells.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Supporting Agencies

Polish State Committee for Scientific Research, Medical University of Warsaw, Poland

How to Cite

Wolosz, D., Walczak, A., Szparecki, G., Dwojak, M., Winiarska, M., Wolinska, E., & Gornicka, B. (2019). Deleted in Liver Cancer 2 (DLC2) protein expression in hepatocellular carcinoma. European Journal of Histochemistry, 63(1). https://doi.org/10.4081/ejh.2019.2981